|
PAWR expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.917670E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.456200E-02 |
| Normal-vs-Stage2 |
3.415100E-04 |
| Normal-vs-Stage3 |
6.318600E-03 |
| Normal-vs-Stage4 |
4.356500E-03 |
| Stage1-vs-Stage2 |
4.260900E-03 |
| Stage1-vs-Stage3 |
1.096820E-01 |
| Stage1-vs-Stage4 |
6.398100E-02 |
| Stage2-vs-Stage3 |
1.913780E-01 |
| Stage2-vs-Stage4 |
4.590400E-01 |
| Stage3-vs-Stage4 |
6.653400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.777600E-02 |
| Normal-vs-AfricanAmerican |
5.867200E-01 |
| Normal-vs-Asian |
2.321400E-01 |
| Caucasian-vs-AfricanAmerican |
3.248800E-01 |
| Caucasian-vs-Asian |
6.737400E-01 |
| AfricanAmerican-vs-Asian |
6.187600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.544700E-03 |
| Normal-vs-Female |
4.637900E-02 |
| Male-vs-Female |
2.264000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.934200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.563410E-03 |
| Normal-vs-Age(61-80Yrs) |
1.995880E-04 |
| Normal-vs-Age(81-100Yrs) |
2.253800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.801400E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.825800E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.938130E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.951000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.652000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.107400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.222600E-01 |
| Classical-VS-Follicular |
1.319480E-03 |
| Classical-VS-Other |
7.813000E-01 |
| Classical-VS-Normal |
1.314990E-01 |
| Tall-VS-Follicular |
2.186400E-01 |
| Tall-VS-Other |
7.690600E-01 |
| Tall-VS-Normal |
9.619600E-02 |
| Follicular-VS-Other |
3.344200E-01 |
| Follicular-VS-Normal |
1.970800E-04 |
| Other-VS-Normal |
3.965000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.433700E-04 |
| Normal-vs-N1 |
3.785400E-01 |
| N0-vs-N1 |
5.355700E-02 |
|
|
